AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
PARACETAMOL + IBUPROFEN + CAFFEINE
34 registrations across 5 African markets— 32 active
Markets with PARACETAMOL + IBUPROFEN + CAFFEINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| IBEX CAPSULES (Each capsule contains Paracetamol/Ibuprofen/Caffeine 325mg/200mg/30mg) | 🇬🇭Ghana | — | active | Apr 2031 |
| IBEX CAPSULES (Each capsule contains Paracetamol/Ibuprofen/Caffeine 325mg/200mg/30mg) | 🇬🇭Ghana | — | active | Apr 2031 |
| GEBEDOL XTRA TABLETS | 🇬🇭Ghana | — | active | Aug 2030 |
| GEBEDOL XTRA TABLETS | 🇬🇭Ghana | — | active | Aug 2030 |
| Pentax Extra Caplet_ Capsule | 🇳🇬Nigeria | Vitabiotics Nigeria Limited | active | Jun 2030 |
| KIBUCET TABLETS | 🇬🇭Ghana | — | active | Jan 2030 |
| KIBUCET TABLETS | 🇬🇭Ghana | — | active | Jan 2030 |
| PICRON PLUS CAPSULE | 🇬🇭Ghana | — | active | Oct 2029 |
| PICRON PLUS CAPSULE | 🇬🇭Ghana | — | active | Oct 2029 |
| PICRON FORTE CAPSULE | 🇬🇭Ghana | — | active | Oct 2029 |
| PICRON FORTE CAPSULE | 🇬🇭Ghana | — | active | Oct 2029 |
| SOCOMOL EXTRA TABLETS | 🇬🇭Ghana | BETAMED INTERNATIONAL FZE AMJAN FREE ZONE, AMJAN EOC NO 01910 UAE | active | Apr 2029 |
| SOCOMOL EXTRA TABLETS | 🇬🇭Ghana | — | active | Apr 2029 |
| FENAID EXTRA TABLETS | 🇬🇭Ghana | — | active | Apr 2029 |
| SOCOMOL EXTRA TABLETS | 🇬🇭Ghana | BETAMED INTERNATIONAL FZE AMJAN FREE ZONE, AMJAN EOC NO 01910 UAE | active | Apr 2029 |
| FENAID EXTRA TABLETS | 🇬🇭Ghana | — | active | Apr 2029 |
| SOCOMOL EXTRA TABLETS | 🇬🇭Ghana | — | active | Apr 2029 |
| FENAID EXTRA TABLETS | 🇬🇭Ghana | — | active | Mar 2029 |
| FENAID EXTRA TABLETS | 🇬🇭Ghana | — | active | Mar 2029 |
| RONADREX MAX TABLETS (Each uncoated tablet contains Paracetamol/Ibuprofen/Caffeine 500mg/400mg/30mg) | 🇬🇭Ghana | — | active | Sept 2028 |
| RONADREX MAX TABLETS (Each uncoated tablet contains Paracetamol/Ibuprofen/Caffeine 500mg/400mg/30mg) | 🇬🇭Ghana | — | active | Sept 2028 |
| RONADREX FORTE TABLETS (Each uncoated tablet contains Paracetamol/Ibuprofen/Caffeine 325mg/200mg/30mg) | 🇬🇭Ghana | — | active | Sept 2028 |
| RONADREX FORTE TABLETS (Each uncoated tablet contains Paracetamol/Ibuprofen/Caffeine 325mg/200mg/30mg) | 🇬🇭Ghana | — | active | Sept 2028 |
| DOLOGAN DENK 250MG, 200MG, 50MG COMPRIME PELLICULE BOITE DE 20 | 🇨🇮Côte d'Ivoire | DENK PHARMA GMBH & CO. KG | active | Jan 2028 |
| FINMOL_PLUS 325/200/30MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Mar 2025 |
| VIBUMOL COMBINATION PRODUCT TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2020 |
| PARACETAMOL +
IBUPROFEN +
CAFFEINE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | DENK PHARMA GMBH & CO. KG | active | — |
| PARACETAMOL +
IBUPROFEN +
CAFFEINE ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | FOURTS(INDIA) LABORATORIES PVT LTD | active | — |
| PARACETAMOL +
IBUPROFEN +
CAFFEINE ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | FOURTS(INDIA) LABORATORIES PVT LTD | active | — |
| PARACETAMOL +
IBUPROFEN +
CAFFEINE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | DENK PHARMA GMBH & CO. KG | active | — |
| PARACETAMOL +
IBUPROFEN +
CAFFEINE ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | BIOMATRIX HEALTHCARE PVT LTD.- | active | — |
| PARACETAMOL +
IBUPROFEN +
CAFFEINE ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | BIOMATRIX HEALTHCARE PVT LTD.- | active | — |
| PARACETAMOL +
IBUPROFEN +
CAFFEINE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | DENK PHARMA GMBH & CO. KG | active | — |
| PARACETAMOL +
IBUPROFEN +
CAFFEINE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | DENK PHARMA GMBH & CO. KG | active | — |
PARACETAMOL + IBUPROFEN + CAFFEINE in Africa — Regulatory Overview
PARACETAMOL + IBUPROFEN + CAFFEINE is registered across 5 African markets with 34 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Uganda, Malawi, Côte d'Ivoire and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 34 registrations, 32 (94%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.